Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Prepaid Assets (2016 - 2025)

Fennec Pharmaceuticals filings provide 16 years of Prepaid Assets readings, the most recent being $1.7 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 43.8% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 43.8% decrease, with the full-year FY2025 number at $1.7 million, down 43.8% from a year prior.
  • Prepaid Assets hit $1.7 million in Q4 2025 for Fennec Pharmaceuticals, up from $898000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $4.5 million in Q1 2024 to a low of $32000.0 in Q2 2023.
  • Median Prepaid Assets over the past 5 years was $931500.0 (2025), compared with a mean of $1.3 million.
  • Biggest five-year swings in Prepaid Assets: surged 30850.0% in 2021 and later tumbled 93.91% in 2022.
  • Fennec Pharmaceuticals' Prepaid Assets stood at $1.0 million in 2021, then tumbled by 93.91% to $63000.0 in 2022, then skyrocketed by 3987.3% to $2.6 million in 2023, then rose by 19.61% to $3.1 million in 2024, then plummeted by 43.8% to $1.7 million in 2025.
  • The last three reported values for Prepaid Assets were $1.7 million (Q4 2025), $898000.0 (Q3 2025), and $965000.0 (Q2 2025) per Business Quant data.